MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering advanced genetic testing services. In this blog post, we will provide detailed information about the MT-TY gene focal segmental glomerulosclerosis (FSGS) and dilated cardiomyopathy (DCM) genetic test.
Test Details
The MT-TY gene focal segmental glomerulosclerosis and dilated cardiomyopathy genetic test is a genetic test that examines the MT-TY gene for mutations associated with FSGS and DCM. FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the filtering units of the kidneys. This can lead to proteinuria (excessive protein in the urine) and progressive kidney damage. DCM is a condition in which the heart becomes enlarged and weakened, leading to decreased pumping efficiency. It can result in symptoms such as fatigue, shortness of breath, and heart failure.
Mutations in the MT-TY gene have been implicated in some cases of FSGS and DCM. The NGS (Next-Generation Sequencing) genetic test involves analyzing the DNA sequence of the MT-TY gene to identify any mutations or variants that may be present. This can help in diagnosing and understanding the genetic basis of FSGS and DCM in individuals.
Test Components
- Test Name: MT-TY Gene Focal Segmental Glomerulosclerosis and Dilated Cardiomyopathy Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Before undergoing the MT-TY gene focal segmental glomerulosclerosis and dilated cardiomyopathy genetic test, it is important to provide the clinical history of the patient. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected with FSGS and DCM. This will help in understanding the inheritance pattern and identifying potential carriers of the MT-TY gene mutation.
Benefits of the Test
The MT-TY gene focal segmental glomerulosclerosis and dilated cardiomyopathy genetic test can provide valuable information for healthcare professionals to guide treatment decisions and genetic counseling for affected individuals and their families. It is particularly useful for individuals with a family history of FSGS or DCM, as well as those who have been diagnosed with these conditions. By identifying the presence of MT-TY gene mutations, healthcare professionals can develop personalized treatment plans and offer appropriate support to patients and their families.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our state-of-the-art facilities and experienced team ensure high-quality results and efficient report delivery. If you have any questions or would like to schedule an appointment for the MT-TY gene focal segmental glomerulosclerosis and dilated cardiomyopathy genetic test, please contact us.
Test Name | MT-TY Gene Focal segmental glomerulosclerosis and dilated cardiomyopath MT-TY related Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MT-TY Gene Focal segmental glomerulosclerosis and dilated cardiomyopath, MT-TY related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TY Gene Focal segmental glomerulosclerosis and dilated cardiomyopath, MT-TY related NGS Genetic DNA Test gene MT-TY |
Test Details |
MT-TY Gene Focal segmental glomerulosclerosis and dilated cardiomyopathy, MT-TY related NGS Genetic Test is a genetic test that examines the MT-TY gene for mutations associated with focal segmental glomerulosclerosis (FSGS) and dilated cardiomyopathy (DCM). FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the filtering units of the kidneys. This can lead to proteinuria (excessive protein in the urine) and progressive kidney damage. Mutations in the MT-TY gene have been implicated in some cases of FSGS. DCM is a condition in which the heart becomes enlarged and weakened, leading to decreased pumping efficiency. It can result in symptoms such as fatigue, shortness of breath, and heart failure. Mutations in the MT-TY gene have also been associated with DCM. The NGS (Next-Generation Sequencing) genetic test involves analyzing the DNA sequence of the MT-TY gene to identify any mutations or variants that may be present. This can help in diagnosing and understanding the genetic basis of FSGS and DCM in individuals. The test can be useful for individuals with a family history of FSGS or DCM, as well as those who have been diagnosed with these conditions. It can provide valuable information for healthcare professionals to guide treatment decisions and genetic counseling for affected individuals and their families. |